Hepatitis A: a new look at an old problem (lecture)

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

Hepatitis A is a serious medico-social problem in the health care system worldwide. In the Russian Federation, hepatitis A virus continues to be the major etiological agent of acute viral hepatitis. The features of Hepatitis A at the present are its frequent association with chronic alcohol intoxication, chronic hepatitis B and C, HIV infection, a tendency to a prolonged course with exacerbations and relapses, the presence of cholestatic syndrome and an autoimmune disorder, more frequent development of severe forms of the disease due to the incidence declined in children and increased in adults. Due to the lack of specific antiviral therapy, vaccination is currently recognized as the most effective measure to combat hepatitis A. Thus, hepatitis A vaccination is included in the National Immunization Program in at least 20 countries, including the United States, China and Brazil. Expansion of the National Immunization Program and inclusion of hepatitis A vaccination will significantly reduce the incidence of this disease in the Russian Federation. The article describes the features of the hepatitis A virus reproduction cycle, including a description of quasi-enveloped form of virions. Current data on the epidemiology and pathogenesis of hepatitis A are presented. Clinical manifestations of manifest forms of hepatitis A are considered. The main and most promising methods of laboratory diagnostics of hepatitis A, as well as methods of specific disease prevention are described.

全文:

受限制的访问

作者简介

Dmitrii Gladin

Saint Petersburg State Pediatric Medical University

编辑信件的主要联系方式.
Email: gladin1975@mail.ru
ORCID iD: 0000-0003-4957-7110
SPIN 代码: 8149-9885

MD, PhD, Head of the Department of Microbiology, Virology and Immunology

巴基斯坦, Saint Petersburg

Nadezhda Kozlova

North-Western State Medical University named after I.I. Mechnikov

Email: spbkns@gmail.com
ORCID iD: 0000-0002-6713-4156
SPIN 代码: 7914-4401

MD, PhD, Associate Professor of Department of Medical Microbiology

俄罗斯联邦, Saint Petersburg

Vladimir Marchenko

North-Western State Medical University named after I.I. Mechnikov

Email: vmarcenco@mail.ru
ORCID iD: 0000-0001-6870-3157
SPIN 代码: 4463-7720

MD, PhD, Associate Professor of Department of Medical Microbiology

俄罗斯联邦, Saint Petersburg

Ilya Baranov

North-Western State Medical University named after I.I. Mechnikov

Email: vodolaz74@yandex.ru
ORCID iD: 0000-0001-9741-0230
SPIN 代码: 9869-5443
俄罗斯联邦, Saint Petersburg

参考

  1. Kaira AN, Svitich OA. Features of the epidemic process of viral hepatitis A and E in the Russian Federation. Epidemiology and Vaccinal Prevention. 2021;20(5):69–78. doi: 10.31631/2073-3046-2021-20-4-69-78 EDN: CZTMYQ
  2. Kaprior E, Mishkina T, Gaiduk I, et al. Autoimmune hepatitis type 1 in a child: clinical case. University Therapeutic Journal. 2024;6(1):176–183. doi: 10.56871/UTJ.2024.28.81.015 EDN: IWAYGS
  3. Karetkina GN. Viral hepatitis A: past, present and future. Infectious diseases: news, views, education. 2014;(3):38–48. EDN: TDOXTB
  4. Kozlova NS, Sosunov AV, Sokolova ED. Viral hepatitis. Enteral hepatitis. Saint Petersburg: North-Western State Medical University named after I.I. Mechnikov. 2021. 80 p. EDN: CDCXKD (In Russ.)
  5. Mikhaylova YuV, Gromov AV, Averyanova EL, Sterlikov SA. The dynamics of viral hepatitis morbidity in the Russian Federation in 2015–2021. Current problems of health care and medical statistics. 2022;(4):269–297. doi: 10.24412/2312-2935-2022-4-269-297 EDN: DVYSXB
  6. Sokurova AM. Specific laboratory diagnosis of viral hepatitis. Pediatrician (St. Petersburg). 2014;5(3):96–100. doi: 10.17816/PED5396-100 EDN: STDBRV
  7. Zinserling AV, Zinserling VA, Anichkov NM. Modern infections: pathologic anatomy and questions of pathogenesis. Saint Petersburg: Sotis; 2002. 352 p. EDN: VAJGXP (In Russ.)
  8. de Almeida Ribeiro CR, Amado LA, Tourinho RS, et al. Accuracy of rapid test for diagnosis of hepatitis A with different infection rate settings and with predictive modeling. Future Microbiol. 2019;14(3):247–258. doi: 10.2217/fmb-2018-0211
  9. Buti M, Jardí R, Bosch A, et al. Detection of hepatitis a virus RNA by PCR-southern blot in serum from patients with acute hepatitis A. Gastroenterol Hepatol. 2001;24(1):1–4. doi: 10.1016/s0210-5705(01)70124-0
  10. Cao G, Jing W, Liu J, Liu M. The global trends and regional differences in incidence and mortality of hepatitis A from 1990 to 2019 and implications for its prevention. Hepatol Int. 2021;15(5):1068–1082. doi: 10.1007/s12072-021-10232-4
  11. Das A, Barrientos R, Shiota T, et al. Gangliosides are essential endosomal receptors for quasi-enveloped and naked hepatitis A virus. Nat Microbiol. 2020;5(9):1069–1078. doi: 10.1038/s41564-020-0727-8
  12. Das A, Rivera-Serrano EE, Yin X, et al. Cell entry and release of quasi-enveloped human hepatitis viruses. Nat Rev Microbiol. 2023;21(9):573–589. doi: 10.1038/s41579-023-00889-z
  13. Desbois D, Couturier E, Mackiewicz V, et al. Epidemiology and genetic characterization of hepatitis A virus genotype IIA. J Clin Microbiol. 2010;48(9):3306–3315. doi: 10.1128/JCM.00667-10
  14. Espul C, Benedetti L, Cuello H, et al. Persistence of immunity from 1 year of age after one or two doses of hepatitis A vaccine given to children in Argentina. Hepat Med. 2012;4:53–60. doi: 10.2147/HMER.S33847
  15. Feinstone SM, Kapikian AZ, Purceli RH. Hepatitis A: detection by immune electron microscopy of a viruslike antigen associated with acute illness. Science. 1973;182(4116):1026–1028. doi: 10.1126/science.182.4116.1026
  16. Fujiwara K, Yokosuka O, Ehata T, et al. Frequent detection of hepatitis A viral RNA in serum during the early convalescent phase of acute hepatitis A. Hepatology. 1997;26(6):1634–1639. doi: 10.1053/jhep.1997.v26.pm0009398009
  17. Gholizadeh O, Akbarzadeh S, Ghazanfari Hashemi M, et al. Hepatitis A: viral structure, classification, life cycle, clinical symptoms, diagnosis error, and vaccination. Can J Infect Dis Med Microbiol. 2023;2023:4263309. doi: 10.1155/2023/4263309
  18. Goswami BB, Burkhardt W III, Cebula TA. Identification of genetic variants of hepatitis A virus. J Virol Methods. 1997;65(1):95–103. doi: 10.1016/s0166-0934(97)02179-4
  19. Hu Y, Arsov I. Nested real-time PCR for hepatitis A detection. Lett Appl Microbiol. 2009;49(5):615–619. doi: 10.1111/j.1472-765X.2009.02713.x
  20. Jothikumar N, Paulmurugan R, Padmanabhan P, et al. Duplex RT-PCR for simultaneous detection of hepatitis A and hepatitis E virus isolated from drinking water samples. J Environ Monit. 2000;2(6):587–590. doi: 10.1039/b004224m
  21. Kaplan G, Totsuka A, Thompson P, et al. Identification of a surface glycoprotein on African green monkey kidney cells as a receptor for hepatitis A virus. EMBO J. 1996;15(16):4282–4296. doi: 10.1002/j.1460-2075.1996.tb00803.x
  22. Lee G-Y, Kim W-K, Cho S, et al. Genotyping and molecular diagnosis of hepatitis A virus in human clinical samples using multiplex PCR-Based next-generation sequencing. Microorganisms. 2022;10(1):100. doi: 10.3390/microorganisms10010100
  23. Lemon SM, Ott JJ, Van Damme P, Shouval D. Type A viral hepatitis: A summary and update on the molecular virology, epidemiology, pathogenesis and prevention. J Hepatol. 2018;68(10):167–184. doi: 10.1016/j.jhep.2017.08.034
  24. Luo L, Zhang F, Chen C, Cai C. Visual simultaneous detection of hepatitis A and B viruses based on a multifunctional molecularly imprinted fluorescence sensor. Anal Chem. 2019;91(24):15748–15756. doi: 10.1021/acs.analchem.9b04001
  25. Liu A, Wang K, Weng S, et al. Development of electrochemical DNA biosensors. TrAC Trends Anal Chem. 2012;37:101–111. doi: 10.1016/j.trac.2012.03.008
  26. Mirzaei J, Ziaee M, Farsad SA, et al. Vaccination against hepatitis a for hemophilic patients: Is it necessary? Hepat Mon. 2016;16(4):e37447. doi: 10.5812/hepatmon.37447
  27. Nelson NP, Link-Gelles R, Hofmeister MG, et al. Update: recommendations of the advisory committee on immunization practices for use of hepatitis A vaccine for postexposure prophylaxis and for preexposure prophylaxis for international travel. Morb Mortal Wkly Rep. 2018;67(43):1216–1220. doi: 10.15585/mmwr.mm6743a5
  28. Pedersini R, Marano C, De Moerlooze L, et al. HAV and HBV vaccination among travellers participating in the National Health and Wellness Survey in five European countries. Travel Med Infect Dis. 2016;14(3):221–232. doi: 10.1016/j.tmaid.2016.03.008
  29. Ticehurst JR, Feinstone SM, Chestnut T, et al. Detection of hepatitis A virus by extraction of viral RNA and molecular hybridization. J Clin Microbiol. 1987;25(10):1822–1829. doi: 10.1128/jcm.25.10.1822-1829.1987
  30. Van Damme P, Pintó RM, Feng Z, et al. Hepatitis A virus infection. Nat Rev Dis Primers. 2023;9(1):51. doi: 10.1038/s41572-023-00461-2
  31. WHO. WHO position paper on hepatitis A vaccines. Weekly Epidemiol Rec. 2012;87(28–29):261–276.

补充文件

附件文件
动作
1. JATS XML
2. Fig. 1. The structure of the virion and the structure of the genome of the hepatitis A virus. Оne large peptide is formed during translation, and is cleaved by proteolysis into three precursor proteins — P1, P2 and P3. Еhe first one, P1, forms four capsid proteins (VP1, VP2, VP3, VP4) through additional proteolysis. P2 consists of three non-structural proteins (2A, 2B and 2C) required for viral replication. P3 consists of the following proteins: 3A is necessary for anchoring P3 to the cell membrane, 3B is a VPg protein, 3C is a cysteine protease that cleaves precursor proteins (P1, P2 and P3) into individual structural and non-structural proteins, 3D is RNA-dependent RNA-polymerase. © O. Gholizadeh, et al. 2023. The figure is adapted from [17].

下载 (166KB)
3. Fig. 2. Genotypes and subtypes of the hepatitis А virus. © S.M. Lemon, et al. 2018. Distributed under CC-BY-NC-ND 4.0 license. Source: borrowed from [23].

下载 (76KB)
4. Fig. 3. Reproduction cycle of the hepatitis A virus. The virus interacts with receptors on the basolateral membrane of the hepatocyte, after which it penetrates into the cell as part of an endosome, followed by undressing and presentation of the genome in the cytoplasm. Translation leads to synthesis of one large precursor polyprotein, which after proteolysis is cleaved into structural and non-structural proteins, some of which required in transcription and translation. In final stages of infection, copies of genomic viral RNA are packaged into viral particles, which are integrated into multivesicular bodies to form quasi-enveloped virions (qHAV). The release of qHAV occurs through the apical or basolateral surface of the hepatocyte, respectively. HAV, hepatitis A virus; IRES, internal ribosome entry site. © O. Gholizadeh и соавт., 2023. The figure is adapted from [17].

下载 (219KB)
5. Fig. 4. Prevalence of viral hepatitis A in the world [28].

下载 (482KB)
6. Fig. 5. Release of quasi-enveloped and non-enveloped HAV virions from hepatocytes. Image adapted with modifications from [12]. © 2023. Springer Nature Limited.

下载 (275KB)
7. Fig. 6. Serological and some biochemical markers during HAV infection. Image adapted with modifications from [30]. © 2023. Springer Nature Limited.

下载 (120KB)
8. Fig. 7. Operating principle of a DNA biosensor. © 2012 Elsevier Ltd. Image adapted with modifications from [25].

下载 (232KB)

版权所有 © Eco-Vector, 2025



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 69634 от 15.03.2021 г.